About The Valley Hospital-Luckow Pavilion
"The Robert and Audrey Luckow Pavilion is a 128,000-square-foot satellite facility of The Valley Hospital. The Luckow Pavilion is home to a variety of outpatient services and physicians' offices, including: - Valley-Mount Sinai Comprehensive Cancer Care - The George R. Jaqua Same Day Services Center - The Ambulatory Infusion Center - The Valley Hospital Breast Imaging Center - The Center for Pain Management - The Valley Hospital Gamma Knife Center - Diagnostic Imaging - MRI, 3T MRI, Breast Imaging For patients' and visitors' convenience, the Luckow Pavilion features complimentary valet parking; an on-site cafe; and a full-service retail pharmacy."
Clinical Trials at The Valley Hospital-Luckow Pavilion
During the past decade, The Valley Hospital-Luckow Pavilion conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 24 clinical trials were completed, i.e. on
average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 19 clinical trials were completed. i.e. 135.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Valley Hospital-Luckow Pavilion" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "SWOG Cancer Research Network" with 7 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "NRG Oncology"
with 3 trials sponsored. Other sponsors include 13 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Valley Hospital-Luckow Pavilion"
#1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "ARMO BioSciences" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were
collaborators in the rest 24 trials.
Clinical Trials Conditions at The Valley Hospital-Luckow Pavilion
According to Clinical.Site data, the most researched conditions in "The Valley Hospital-Luckow Pavilion" are
"Breast Cancer" (5 trials), "Recurrent Squamous Cell Lung Carcinoma" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Invasive Breast Carcinoma" (3 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "The Valley Hospital-Luckow Pavilion" in a lesser frequency.
Clinical Trials Intervention Types at The Valley Hospital-Luckow Pavilion
Most popular intervention types in "The Valley Hospital-Luckow Pavilion" are "Drug" (51 trials), "Other" (32 trials), "Biological" (24 trials), "Procedure" (12 trials) and "Radiation" (11 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (17 trials), "Laboratory Biomarker Analysis" (13 trials), "Computed Tomography" (10 trials), "Pembrolizumab" (8 trials) and "Questionnaire Administration" (8 trials). Other intervention names were less common.
Clinical Trials Genders at The Valley Hospital-Luckow Pavilion
The vast majority of trials in "The Valley Hospital-Luckow Pavilion" are
43 trials for "All" genders, 14 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at The Valley Hospital-Luckow Pavilion
Currently, there are NaN active trials in "The Valley Hospital-Luckow Pavilion".
undefined are not yet recruiting,
12 are recruiting,
33 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in The Valley Hospital-Luckow Pavilion,
1 suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in The Valley Hospital-Luckow Pavilion, 2 "Phase 1"
clinical trials were conducted, 20 "Phase 2" clinical
trials and 39 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 3 trials that are defined as “Not Applicable".